Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability

Digestive Diseases and Sciences
Peter MangellBengt Jeppsson

Abstract

The purpose of this work was to investigate whether a probiotic bacterium, Lactobacillus plantarum 299v, could affect Escherichia coli-induced passage of mannitol across the intestinal wall. Sprague-Dawley rats were pretreated for one week by either tube feeding with L. plantarum 299v twice daily, free access to L. plantarum 299v by adding the bacterium in the drinking water, or negative control receiving regular feeding. Intestinal segments were mounted in Ussing chambers and the mucosa was exposed to control medium, E. coli, and L. plantarum 299v (alone or together). [14C]Mannitol was added as a marker of intestinal permeability and samples were taken from the serosal side. E. coli exposure induced a 53% increase in mannitol passage across the intestinal wall (P < 0.05). One week of pretreatment with L. plantarum 299v in the drinking water abolished the E. coli-induced increase in permeability. Tube feeding for one week or short-term addition of L. plantarum 299v in the Ussing chambers had no effect on the permeability provoked by E. coli challenge. Notably, L. plantanum 299v itself did not change the intestinal passage of mannitol. These data demonstrate that pretreatment with L. plantarum 299v, which is a probiotic bacteriu...Continue Reading

Citations

Jul 9, 2003·Current Treatment Options in Gastroenterology·Martin H. Floch
Feb 22, 2007·The Journal of Nutrition·Michael de Vrese, Philippe R Marteau
Aug 8, 2008·Current Opinion in Clinical Nutrition and Metabolic Care·Francisco J PennaJacques R Nicoli
Mar 26, 2009·Current Opinion in Clinical Nutrition and Metabolic Care·Matthias V Kopp, Peter Salfeld
Mar 13, 2010·American Journal of Physiology. Gastrointestinal and Liver Physiology·Jurgen KarczewskiJerry M Wells
Jan 10, 2012·Alimentary Pharmacology & Therapeutics·G ClarkeE M Quigley
Nov 4, 2015·Frontiers in Cellular Neuroscience·John R KellyNiall P Hyland
Jan 10, 2019·Current Opinion in Pediatrics·Lisa G PellPhilip M Sherman
Jan 28, 2003·Journal of Pediatric Gastroenterology and Nutrition·Henrik KöhlerW Allan Walker
Feb 11, 2005·Current Opinion in Gastroenterology·David R Mack, Sylvie Lebel
Jan 27, 2007·The Cochrane Database of Systematic Reviews·F LirussiR Orlando
Sep 5, 2006·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Peter MangellBengt Jeppsson
Jan 3, 2008·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M V KoppR Urbanek
Jun 6, 2008·Alimentary Pharmacology & Therapeutics·R Spiller
Jul 14, 2010·FEMS Microbiology Letters·Rachel C AndersonNicole C Roy
Aug 10, 2010·The British Journal of Nutrition·Marloes A A SchepensIngeborg M J Bovee-Oudenhoven
Oct 26, 2011·Microbial Cell Factories·Jerry M Wells
Jan 20, 2017·The British Journal of Nutrition·Peter A BronJerry M Wells
Sep 19, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yiyun LiuWeijun Chen
Jan 19, 2012·Nutrients·Siv Ahrne, Marie-Louise Johansson Hagslatt
Nov 22, 2011·Nature Reviews. Microbiology·Peter A BronMichiel Kleerebezem
Jul 4, 2013·European Journal of Gastroenterology & Hepatology·Claire JonesMark A Taylor
Mar 9, 2017·Probiotics and Antimicrobial Proteins·Hamza Ait SeddikDjamel Drider
Sep 10, 2020·Acta Cirúrgica Brasileira·Mehmet MetinGökhan Köylüoğlu
Apr 11, 2003·Current Opinion in Infectious Diseases·George T Macfarlane, John H Cummings
Feb 11, 2005·Current Opinion in Gastroenterology·Richard N Fedorak, Karen L Madsen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition
C E McNaughtJ MacFie
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
D GoossensR Stockbrügger
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
Peter MangellBengt Jeppsson
© 2022 Meta ULC. All rights reserved